These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 32850151)

  • 81. Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Pan C; Chen L; Lu C; Zhang W; Xia JA; Sklar MC; Du B; Brochard L; Qiu H
    Am J Respir Crit Care Med; 2020 May; 201(10):1294-1297. PubMed ID: 32200645
    [No Abstract]   [Full Text] [Related]  

  • 82. [It's world war at CoViD-19. The first battle on the front of the viral invasion against the exitus for interstitial pneumonia was decisive.].
    Basta G; Del Turco S; Caselli C; Melani L; Vianello A
    Recenti Prog Med; 2020 Apr; 111(4):238-252. PubMed ID: 32319446
    [TBL] [Abstract][Full Text] [Related]  

  • 83. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
    Michalski JE; Kurche JS; Schwartz DA
    Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.
    Tian S; Hu W; Niu L; Liu H; Xu H; Xiao SY
    J Thorac Oncol; 2020 May; 15(5):700-704. PubMed ID: 32114094
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
    Criel M; Falter M; Jaeken J; Van Kerrebroeck M; Lefere I; Meylaerts L; Mesotten D; Vander Laenen M; Fivez T; Thomeer M; Ruttens D
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32398294
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review.
    Chen X; Zhang G; Hao SY; Bai L; Lu JJ
    Chin Med Sci J; 2020 Sep; 35(3):254-261. PubMed ID: 32972503
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
    Flikweert AW; Grootenboers MJJH; Yick DCY; du Mée AWF; van der Meer NJM; Rettig TCD; Kant MKM
    J Crit Care; 2020 Oct; 59():149-155. PubMed ID: 32674001
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.
    Imamura T; Nikhil N
    J Card Surg; 2020 Oct; 35(10):2872-2873. PubMed ID: 33043665
    [No Abstract]   [Full Text] [Related]  

  • 92. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.
    Crisan-Dabija R; Pavel CA; Popa IV; Tarus A; Burlacu A
    J Proteome Res; 2020 Nov; 19(11):4327-4338. PubMed ID: 32883081
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
    Zhan X; Liu B; Tong ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Sep; 43(9):728-732. PubMed ID: 32894907
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
    Huang W; Wu Q; Chen Z; Xiong Z; Wang K; Tian J; Zhang S
    J Infect; 2021 Feb; 82(2):e5-e7. PubMed ID: 32998036
    [No Abstract]   [Full Text] [Related]  

  • 95. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy.
    Vitiello A; Pelliccia C; Ferrara F
    SN Compr Clin Med; 2020; 2(10):1709-1712. PubMed ID: 32875276
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
    Zhang C; Wu Z; Li JW; Tan K; Yang W; Zhao H; Wang GQ
    J Med Virol; 2021 Mar; 93(3):1378-1386. PubMed ID: 33107641
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity.
    Wigén J; Löfdahl A; Bjermer L; Elowsson-Rendin L; Westergren-Thorsson G
    Respir Med X; 2020 Nov; 2():100023. PubMed ID: 33083782
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Assessment and characterisation of post-COVID-19 manifestations.
    Kamal M; Abo Omirah M; Hussein A; Saeed H
    Int J Clin Pract; 2021 Mar; 75(3):e13746. PubMed ID: 32991035
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-Term Respiratory and Neurological Sequelae of COVID-19.
    Wang F; Kream RM; Stefano GB
    Med Sci Monit; 2020 Nov; 26():e928996. PubMed ID: 33177481
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
    McDonald LT
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L257-L265. PubMed ID: 33355522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.